Patrice Rioux - 01 Jan 2024 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNPR	Stock Options	Award	$0	+10,000		$0.000000	10,000	01 Jan 2024	Common Stock	10,000	$0.3402	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Stock Options vesting commenced on January 1, 2024 as follows: 833 on January 31, 2024 and each subsequent month-end thereafter.